ANGO

AngioDynamics Inc

Add to Watchlist

Advanced Chart

9.400

-0.170(-1.780%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

9.720

Open

9.670

VWAP

9.41

Vol

259.21K

Mkt Cap

381.71M

Low

9.310

Amount

2.44M

EV/EBITDA(TTM)

636.63

Total Shares

40.05M

350.15M

EV/OCF(TTM)

P/S(TTM)

1.38

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q1

FY2025Q4

75.25M

+3.29%

-0.065

+62.5%

72.87M

+7.97%

-0.085

-22.73%

74.26M

+4.61%

-0.120

+100%

Estimates Revision

The market is revising Upward the revenue expectations for AngioDynamics, Inc. (ANGO) for FY2025, with the revenue forecasts being adjusted by 0.12% over the past three months. During the same period, the stock price has changed by -9.09%.

Revenue Estimates for FY2025

Revise Upward

+0.12%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-22.06%

In Past 3 Month

Stock Price

Go Down

-9.09%

In Past 3 Month

2 Analyst Rating

64.89% Upside

Wall Street analysts forecast ANGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANGO is 15.50 USD with a low forecast of 15.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

64.89% Upside

Current: 9.400

Low

15.00

Averages

15.50

High

16.00

64.89% Upside

Current: 9.400

Low

15.00

Averages

15.50

High

16.00

HC Wainwright & Co.

Yi Chen

Strong Buy

Maintains

$15 → $16

2025-04-07

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$15 → $16

2025-04-07

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Yi Chen

Strong Buy

Maintains

$14 → $15

2025-01-10

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$14 → $15

2025-01-10

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Yi Chen

Strong Buy

Reiterates

$14

2024-12-10

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$14

2024-12-10

Reiterates

Strong Buy

Reason

Canaccord Genuity

William Plovanic

Strong Buy

Maintains

$13 → $12

2024-10-04

Reason

Canaccord Genuity

William Plovanic

Price Target

$13 → $12

2024-10-04

Maintains

Strong Buy

Reason

Canaccord lowered the firm's price target on AngioDynamics to $12 from $13 and keeps a Buy rating on the shares. The firm said they believe they delivered another solid quarter with $67.5M in Q1/25 revenue, but think the stock reaction is driven by missing the consensus revenue estimate and the seasonally high Q1 cash burn.

HC Wainwright & Co.

Yi Chen

Strong Buy

Reiterates

$14

2024-10-04

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$14

2024-10-04

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Yi Chen

Strong Buy

Reiterates

$14

2024-09-20

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$14

2024-09-20

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for AngioDynamics Inc (ANGO.O) is -28.57, compared to its 5-year average forward P/E of -67.01. For a more detailed relative valuation and DCF analysis to assess AngioDynamics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-67.01

Current PE

-28.57

Overvalued PE

328.10

Undervalued PE

-462.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-11.28

Current EV/EBITDA

71.46

Overvalued EV/EBITDA

171.92

Undervalued EV/EBITDA

-194.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.78

Current PS

1.24

Overvalued PS

2.64

Undervalued PS

0.93

Financials

Annual

Quarterly

FY2025Q3

YoY :

-4.23%

72.00M

Total Revenue

FY2025Q3

YoY :

-42.68%

-6.65M

Operating Profit

FY2025Q3

YoY :

-97.65%

-4.41M

Net Income after Tax

FY2025Q3

YoY :

-97.64%

-0.11

EPS - Diluted

FY2025Q3

YoY :

-8.70%

-14.96M

Free Cash Flow

FY2025Q3

YoY :

+16.22%

50.36

Gross Profit Margin - %

FY2025Q3

YoY :

+37.43%

-9.95

FCF Margin - %

FY2025Q3

YoY :

-97.55%

-6.12

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

50.0K

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

135.8K

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

50.0K

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

135.8K

USD

Months

0-12

0.0

USD

Months

ANGO News & Events

Events Timeline

2025-04-02 (ET)

2025-04-02

06:36:19

AngioDynamics raises FY25 adjusted EPS view to (31c)-(34c) from (34c)-(38c)

2025-04-02

06:32:05

AngioDynamics reports Q3 adjusted EPS (8c), consensus (13c)

2025-01-30 (ET)

2025-01-30

06:35:34

AngioDynamics initiates Auryon Atherectomy System combination study

News

9.5

04-03Yahoo Finance

AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

4.5

04-02Benzinga

Gold Moves Higher; US Private Sector Job Growth Tops Estimates

9.5

04-02Benzinga

Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance

People Also Watch

MBCN

Middlefield Banc Corp

TuHURA Biosciences Inc

Orchestra Biomed Holdings Inc

Hawthorn Bancshares Inc

Knot Offshore Partners LP

FAQ

What is AngioDynamics Inc (ANGO) stock price today?

The current price of ANGO is 9.4 USD — it has decreased -1.78 % in the last trading day.

ANGO

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

ANGO News & Events

Events Timeline

News

People Also Watch

FAQ

What is AngioDynamics Inc (ANGO) stock price today?

What is AngioDynamics Inc (ANGO)'s business?

What is the price predicton of ANGO Stock?

What is AngioDynamics Inc (ANGO)'s revenue for the last quarter?

What is AngioDynamics Inc (ANGO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for AngioDynamics Inc (ANGO)'s fundamentals?

How many employees does AngioDynamics Inc (ANGO). have?

What is AngioDynamics Inc (ANGO) market cap?